NASHVILLE, Tenn., May 05, 2025--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its financial results for the first ...
Harrow (HROW) shares soared 8.4% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 9, 2025 NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results